Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Evenamide

    Client Email Product

    Evenamide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    1
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    1
    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    13
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Data from Newron’s Study and An Evenamide Clinical Outlook Presented at The SIRS
    Data from Newron’s Study and An Evenamide Clinical Outlook Presented at The SIRS

    https://www.businesswire.com/news/home/20240408718700/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide
    Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide

    https://www.businesswire.com/news/home/20240104787993/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Newron Completes Enrollment of Schizophrenia Patients in Study 008A
    Newron Completes Enrollment of Schizophrenia Patients in Study 008A

    https://www.businesswire.com/news/home/20231229998281/en

    BUSINESSWIRE
    29 Dec 2023
    Share Share
    Newron to Present Three Posters on Its Clinical Program Evaluating Evenamide
    Newron to Present Three Posters on Its Clinical Program Evaluating Evenamide

    https://www.businesswire.com/news/home/20231004618103/en

    BUSINESSWIRE
    04 Oct 2023
    Share Share
    Newron Reports Compelling Topline Results From All Patients in Study 014
    Newron Reports Compelling Topline Results From All Patients in Study 014

    https://www.businesswire.com/news/home/20230320005300/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    Newron Reports Striking Results From PII Clinical Trial Evaluating Evenamide
    Newron Reports Striking Results From PII Clinical Trial Evaluating Evenamide

    https://www.businesswire.com/news/home/20230216005377/en

    BUSINESSWIRE
    16 Feb 2023
    Share Share
    Newron striking six-month interim results from its exploratory trial evenamide
    Newron striking six-month interim results from its exploratory trial evenamide

    https://www.businesswire.com/news/home/20230103005219/en

    BUSINESSWIRE
    03 Jan 2023
    Share Share
    Newron provides H1 2022 results and updates on R&D and business activities
    Newron provides H1 2022 results and updates on R&D and business activities

    https://www.businesswire.com/news/home/20220915005468/en

    BUSINESSWIRE
    15 Sep 2022
    Share Share
    Newron presents encouraging interim results for evenamide in TRS
    Newron presents encouraging interim results for evenamide in TRS

    https://www.businesswire.com/news/home/20220606005992/en

    BUSINESSWIRE
    07 Jun 2022
    Share Share
    Newron Initiates Pivotal Study with Evenamide in Patients with Schizophrenia
    Newron Initiates Pivotal Study with Evenamide in Patients with Schizophrenia

    https://www.businesswire.com/news/home/20210906005182/en

    BUSINESSSWIRE
    06 Sep 2021
    Share Share
    Tiziana Reports Phase 1 Clinical Data Demonste Oral Treatment with Foralumab
    Tiziana Reports Phase 1 Clinical Data Demonste Oral Treatment with Foralumab

    https://www.businesswire.com/news/home/20200109005415/en

    BUSINESS WIRE
    09 Jan 2020
    Share Share
    Newron Receives First Tranche from Financing Agreement with EIB
    Newron Receives First Tranche from Financing Agreement with EIB

    https://www.biospace.com/article/releases/newron-receives-first-tranche-from-financing-agreement-with-european-investment-bank-eib-/?s=75

    BIOSPACE
    28 Jun 2019
    Share Share
    Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
    Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors

    https://www.businesswire.com/news/home/20180208006174/en/Newron-Pharmaceuticals-S.p.A.-Announces-Change-Board-Directors

    BUSINESSWIRE
    18 Feb 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search